NRF2-regulation in brain health and disease: Implication of cerebral inflammation

Neuropharmacology

Volumn 79, Issue , 2014, Pages 298-306

  Sandberg, Mats ^a   Patil, Jaspal ^a   D'Angelo, Barbara ^a   Weber, Stephen G ^b   Mallard, Carina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Anti oxidants; Neuroinflammation; NRF2

Indexed keywords

BARDOXOLONE METHYL; CELECOXIB; CURCUMIN; FUMARIC ACID DIMETHYL ESTER; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE P38; SPIRULINA EXTRACT; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; TRITERPENOID; VALPROIC ACID;

ARTHRITIS; ARTICLE; AUTISM; AUTOPHAGY; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC KIDNEY DISEASE; DEGENERATIVE DISEASE; DRUG MECHANISM; ENCEPHALITIS; EPIGENETICS; GENE DELETION; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARKINSON DISEASE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REGULATORY MECHANISM; SCHIZOPHRENIA; SLEEP DISORDER; ANIMAL; BRAIN; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; HUMANS; INFLAMMATION; NF-E2-RELATED FACTOR 2; SIGNAL TRANSDUCTION;

EID: 84891600336     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.11.004     Document Type: Review

References (128)

1. F.H. Bardai, and S.R. D'Mello Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta J. Neurosci. 31 2011 1746 1751
2. G. Bjorkoy, T. Lamark, A. Brech, H. Outzen, M. Perander, A. Overvatn, H. Stenmark, and T. Johansen p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death J. Cell Biol. 171 2005 603 614 (Pubitemid 41668720)
3. M.L. Block, L. Zecca, and J.S. Hong Microglia-mediated neurotoxicity: uncovering the molecular mechanisms Nat. Rev. Neurosci. 8 2007 57 69 (Pubitemid 46011999)
4. D.A. Bloom, and A.K. Jaiswal Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression J. Biol. Chem. 278 2003 44675 44682 (Pubitemid 37377224)
5. N.C. Burton, T.W. Kensler, and T.R. Guilarte In vivo modulation of the Parkinsonian phenotype by Nrf2 Neurotoxicology 27 2006 1094 1100 (Pubitemid 44838961)
6. Z. Cai, L.W. Fan, A. Kaizaki, L.T. Tien, T. Ma, Y. Pang, S. Lin, R.C. Lin, and K.L. Simpson Neonatal systemic exposure to lipopolysaccharide enhances susceptibility of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life Dev. Neurosci. 35 2-3 2013 155 171
7. L. Chen, X. Xin, Q. Yuan, D. Su, and W. Liu Phytochemical properties and antioxidant capacities of various colored berries J. Sci. Food Agric. 2013 May 7 10.1002/jsfa.6216 [Epub ahead of print]
8. S. Chowdhry, Y. Zhang, M. McMahon, C. Sutherland, A. Cuadrado, and J.D. Hayes Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity Oncogene 32 2013 3765 3781
9. C.M. Clements, R.S. McNally, B.J. Conti, T.W. Mak, and J.P. Ting DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2 Proc. Natl. Acad. Sci. U. S. A. 103 2006 15091 15096 (Pubitemid 44583169)
10. A.L. Cook, A.M. Vitale, S. Ravishankar, N. Matigian, G.T. Sutherland, J. Shan, R. Sutharsan, C. Perry, P.A. Silburn, and G.D. Mellick et al. NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's disease PLoS One 6 2011 e21907
11. F. Correa, C. Mallard, M. Nilsson, and M. Sandberg Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3beta Neurobiol. Dis. 44 2011 142 151
12. F. Correa, E. Ljunggren, C. Mallard, M. Nilsson, S.G. Weber, and M. Sandberg The Nrf2-inducible antioxidant defense in astrocytes can be both up- and down-regulated by activated microglia:Involvement of p38 MAPK Glia 59 2011 785 799
13. F. Correa, C. Mallard, M. Nilsson, and M. Sandberg Dual TNFalpha-induced effects on NRF2 mediated antioxidant defence in astrocyte-rich cultures: role of protein kinase activation Neurochem. Res. 37 2012 2842 2855
14. F. Correa, E. Ljunggren, J. Patil, X. Wang, H. Hagberg, C. Mallard, and M. Sandberg Time-dependent effects of systemic lipopolysaccharide injection on regulators of antioxidant defence Nrf2 and PGC-1alpha in the neonatal rat brain Neuroimmunomodulation 20 2013 185 193
15. C.W. Cotman, N.C. Berchtold, and L.A. Christie Exercise builds brain health: key roles of growth factor cascades and inflammation Trends Neurosci. 30 2007 464 472 (Pubitemid 47374831)
16. S.B. Cullinan, D. Zhang, M. Hannink, E. Arvisais, R.J. Kaufman, and J.A. Diehl Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival Mol. Cell. Biol. 23 2003 7198 7209 (Pubitemid 37211002)
17. C. Cummings Melatonin for the management of sleep disorders in children and adolescents Paediatr. Child Health 17 2012 331 336
18. B. D'Angelo, C.J. Ek, M. Sandberg, and C. Mallard Expression of the Nrf2-system at the blood-CSF barrier is modulated by neonatal inflammation and hypoxia-ischemia J. Inherit. Metab. Dis. 36 2013 479 490
19. D. Devos, T. Lebouvier, B. Lardeux, M. Biraud, T. Rouaud, H. Pouclet, E. Coron, S. Bruley des Varannes, P. Naveilhan, and J.M. Nguyen et al. Colonic inflammation in Parkinson's disease Neurobiol. Dis. 50 2013 42 48
20. S. Dhakshinamoorthy, and A.K. Jaiswal Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H: quinone oxidoreductase1 gene Oncogene 20 2001 3906 3917 (Pubitemid 32646201)
21. S. Dhakshinamoorthy, A.K. Jain, D.A. Bloom, and A.K. Jaiswal Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants J. Biol. Chem. 280 2005 16891 16900 (Pubitemid 41389148)
22. A.T. Dinkova-Kostova, W.D. Holtzclaw, R.N. Cole, K. Itoh, N. Wakabayashi, Y. Katoh, M. Yamamoto, and P. Talalay Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants Proc. Natl. Acad. Sci. U. S. A. 99 2002 11908 11913 (Pubitemid 34994497)
23. S. Espada, A.I. Rojo, M. Salinas, and A. Cuadrado The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection J. Neurochem. 110 2009 1107 1119
24. A. Fragoulis, J. Laufs, S. Muller, U. Soppa, S. Siegl, L.K. Reiss, M. Tohidnezhad, C. Rosen, K. Tenbrock, and D. Varoga et al. Sulforaphane has opposing effects on TNF-alpha stimulated and unstimulated synoviocytes Arthritis Res. Ther. 14 2012 R220
25. L. Gan, M.R. Vargas, D.A. Johnson, and J.A. Johnson Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model J. Neurosci. 32 2012 17775 17787
26. L. Gao, J. Wang, K.R. Sekhar, H. Yin, N.F. Yared, S.N. Schneider, S. Sasi, T.P. Dalton, M.E. Anderson, and J.Y. Chan et al. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3 J. Biol. Chem. 282 2007 2529 2537 (Pubitemid 47076775)
27. C. Gemma, M.H. Mesches, B. Sepesi, K. Choo, D.B. Holmes, and P.C. Bickford Diets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar beta-adrenergic function and increases in proinflammatory cytokines J. Neurosci. 22 2002 6114 6120 (Pubitemid 35387654)
28. R. Gold, L. Kappos, D.L. Arnold, A. Bar-Or, G. Giovannoni, K. Selmaj, C. Tornatore, M.T. Sweetser, M. Yang, and S.I. Sheikh et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis N. Engl. J. Med. 367 2012 1098 1107
29. S.S. Gounder, S. Kannan, D. Devadoss, C.J. Miller, K.S. Whitehead, S.J. Odelberg, M.A. Firpo, R. Paine 3rd, J.R. Hoidal, and E.D. Abel et al. Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training PLoS One 7 2012 e45697
30. N. Harada, M. Kanayama, A. Maruyama, A. Yoshida, K. Tazumi, T. Hosoya, J. Mimura, T. Toki, J.M. Maher, and M. Yamamoto et al. Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages Arch. Biochem. Biophys. 508 2011 101 109
31. C. Holmes, C. Cunningham, E. Zotova, J. Woolford, C. Dean, S. Kerr, D. Culliford, and V.H. Perry Systemic inflammation and disease progression in Alzheimer disease Neurology 73 2009 768 774
32. H.C. Huang, T. Nguyen, and C.B. Pickett Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2 Proc. Natl. Acad. Sci. U. S. A. 97 2000 12475 12480
33. H.C. Huang, K. Xu, and Z.F. Jiang Curcumin-mediated neuroprotection against amyloid-beta-induced mitochondrial dysfunction involves the inhibition of GSK-3beta J. Alzheimers Dis. 32 2012 981 996
34. A.F. Hubbs, S.A. Benkovic, D.B. Miller, J.P. O'Callaghan, L. Battelli, D. Schwegler-Berry, and Q. Ma Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2 Am. J. Pathol. 170 2007 2068 2076 (Pubitemid 47339279)
35. N.G. Innamorato, A.I. Rojo, A.J. Garcia-Yague, M. Yamamoto, M.L. de Ceballos, and A. Cuadrado The transcription factor Nrf2 is a therapeutic target against brain inflammation J. Immunol. 181 2008 680 689
36. N.G. Innamorato, A. Jazwa, A.I. Rojo, C. Garcia, J. Fernandez-Ruiz, A. Grochot-Przeczek, A. Stachurska, A. Jozkowicz, J. Dulak, and A. Cuadrado Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1 PLoS One 5 2010 e11838
37. K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, and I. Hatayama et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements Biochem. Biophys. Res. Commun. 236 1997 313 322 (Pubitemid 27373291)
38. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J.D. Engel, and M. Yamamoto Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes Dev. 13 1999 76 86 (Pubitemid 29045117)
39. A.K. Jain, and A.K. Jaiswal GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2 J. Biol. Chem. 282 2007 16502 16510 (Pubitemid 47100395)
40. A. Jain, T. Lamark, E. Sjottem, K.B. Larsen, J.A. Awuh, A. Overvatn, M. McMahon, J.D. Hayes, and T. Johansen p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription J. Biol. Chem. 285 2010 22576 22591
41. R.J. Jakel, J.A. Townsend, A.D. Kraft, and J.A. Johnson Nrf2-mediated protection against 6-hydroxydopamine Brain Res. 1144 2007 192 201 (Pubitemid 46440842)
42. W. Jin, H. Wang, W. Yan, L. Zhu, Z. Hu, Y. Ding, and K. Tang Role of Nrf2 in protection against traumatic brain injury in mice J. Neurotrauma 26 2009 131 139
43. Y.N. Jin, Y.V. Yu, S. Gundemir, C. Jo, M. Cui, K. Tieu, and G.V. Johnson Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin PLoS One 8 2013 e57932
44. H.K. Jyrkkanen, S. Kuosmanen, M. Heinaniemi, H. Laitinen, E. Kansanen, E. Mella-Aho, H. Leinonen, S. Yla-Herttuala, and A.L. Levonen Novel insights into the regulation of antioxidant-response-element-mediated gene expression by electrophiles: induction of the transcriptional repressor BACH1 by Nrf2 Biochem. J. 440 2011 167 174
45. N.A. Kaidery, R. Banerjee, L. Yang, N.A. Smirnova, D.M. Hushpulian, K.T. Liby, C.R. Williams, M. Yamamoto, T.W. Kensler, and R.R. Ratan et al. Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's disease Antioxid. Redox Signal 18 2013 139 157
46. K. Kanninen, T.M. Malm, H.K. Jyrkkanen, G. Goldsteins, V. Keksa-Goldsteine, H. Tanila, M. Yamamoto, S. Yla-Herttuala, A.L. Levonen, and J. Koistinaho Nuclear factor erythroid 2-related factor 2 protects against beta amyloid Mol. Cell. Neurosci. 39 2008 302 313
47. K. Kanninen, A.R. White, J. Koistinaho, and T. Malm Targeting glycogen synthase Kinase-3beta for therapeutic benefit against oxidative stress in Alzheimer's disease: involvement of the Nrf2-ARE pathway Int. J. Alzheimers Dis. 2011 2011 985085
48. S. Kapeta, N. Chondrogianni, and E.S. Gonos Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts J. Biol. Chem. 285 2010 8171 8184
49. L. Kappos, R. Gold, D.H. Miller, D.G. Macmanus, E. Havrdova, V. Limmroth, C.H. Polman, K. Schmierer, T.A. Yousry, and M. Yang et al. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study Lancet 372 2008 1463 1472
50. J.W. Kaspar, and A.K. Jaiswal An autoregulatory loop between Nrf2 and Cul3-Rbx1 controls their cellular abundance J. Biol. Chem. 285 2010 21349 21358
51. Y.S. Keum, S. Yu, P.P. Chang, X. Yuan, J.H. Kim, C. Xu, J. Han, A. Agarwal, and A.N. Kong Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells Cancer Res. 66 2006 8804 8813 (Pubitemid 44449198)
52. H.J. Kim, and N.D. Vaziri Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure Am. J. Physiol. Ren. Physiol. 298 2010 F662 F671
53. J.E. Kim, D.J. You, C. Lee, C. Ahn, J.Y. Seong, and J.I. Hwang Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation Cell Signal 22 2010 1645 1654
54. K.H. Kim, J.H. Lyu, S.T. Koo, S.R. Oh, H.K. Lee, K.S. Ahn, R.T. Sadikot, and M. Joo MyD88 is a mediator for the activation of Nrf2 Biochem. Biophys. Res. Commun. 404 2011 46 51
55. J. Kirby, E. Halligan, M.J. Baptista, S. Allen, P.R. Heath, H. Holden, S.C. Barber, C.A. Loynes, C.A. Wood-Allum, and J. Lunec et al. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS Brain 128 2005 1686 1706 (Pubitemid 41373687)
56. A. Kobayashi, M.I. Kang, H. Okawa, M. Ohtsuji, Y. Zenke, T. Chiba, K. Igarashi, and M. Yamamoto Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2 Mol. Cell. Biol. 24 2004 7130 7139 (Pubitemid 39014439)
57. A. Kobayashi, M.I. Kang, Y. Watai, K.I. Tong, T. Shibata, K. Uchida, and M. Yamamoto Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1 Mol. Cell. Biol. 26 2006 221 229
58. M. Komatsu, S. Waguri, M. Koike, Y.S. Sou, T. Ueno, T. Hara, N. Mizushima, J. Iwata, J. Ezaki, and S. Murata et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice Cell 131 2007 1149 1163 (Pubitemid 350235021)
59. M. Komatsu, H. Kurokawa, S. Waguri, K. Taguchi, A. Kobayashi, Y. Ichimura, Y.S. Sou, I. Ueno, A. Sakamoto, and K.I. Tong et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 Nat. Cell Biol. 12 2010 213 223
60. V. Konstantinidou, M.I. Covas, R. Sola, and M. Fito Up-to date knowledge on the in vivo transcriptomic effect of the Mediterranean diet in humans Mol. Nutr. Food Res. 57 2013 772 783
61. C.S. Ku, T.X. Pham, Y. Park, B. Kim, M.S. Shin, I. Kang, and J. Lee Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-kappaB pathway in macrophages and splenocytes Biochim. Biophys. Acta 1830 2013 2981 2988
62. M.K. Kwak, N. Wakabayashi, J.L. Greenlaw, M. Yamamoto, and T.W. Kensler Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway Mol. Cell. Biol. 23 2003 8786 8794 (Pubitemid 37433379)
63. M.K. Kwak, N. Wakabayashi, K. Itoh, H. Motohashi, M. Yamamoto, and T.W. Kensler Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival J. Biol. Chem. 278 2003 8135 8145 (Pubitemid 36800555)
64. M.K. Kwak, J.M. Cho, B. Huang, S. Shin, and T.W. Kensler Role of increased expression of the proteasome in the protective effects of sulforaphane against hydrogen peroxide-mediated cytotoxicity in murine neuroblastoma cells Free Radic. Biol. Med. 43 2007 809 817 (Pubitemid 47103310)
65. T. Lamark, V. Kirkin, I. Dikic, and T. Johansen NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets Cell Cycle 8 2009 1986 1990
66. I. Lastres-Becker, A. Ulusoy, N.G. Innamorato, G. Sahin, A. Rabano, D. Kirik, and A. Cuadrado alpha-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease Hum. Mol. Genet. 21 2012 3173 3192
67. A. Lau, X.J. Wang, F. Zhao, N.F. Villeneuve, T. Wu, T. Jiang, Z. Sun, E. White, and D.D. Zhang A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62 Mol. Cell. Biol. 30 2010 3275 3285
68. A.L. Levonen, A. Landar, A. Ramachandran, E.K. Ceaser, D.A. Dickinson, G. Zanoni, J.D. Morrow, and V.M. Darley-Usmar Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products Biochem. J. 378 2004 373 382 (Pubitemid 38367228)
69. F. Liu, J.L. Nguyen, J.D. Hulleman, L. Li, and J.C. Rochet Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease J. Neurochem. 105 2008 2435 2453 (Pubitemid 351782273)
70. G.H. Liu, J. Qu, and X. Shen NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK Biochim. Biophys. Acta 1783 2008 713 727
71. I. Lourida, M. Soni, J. Thompson-Coon, N. Purandare, I.A. Lang, O.C. Ukoumunne, and D.J. Llewellyn Mediterranean diet, cognitive function, and dementia: a systematic review Epidemiology 24 2013 479 489
72. P. Meng, H. Yoshida, T. Matsumiya, T. Imaizumi, K. Tanji, F. Xing, R. Hayakari, J. Dempoya, T. Tatsuta, and T. Aizawa-Yashiro et al. Carnosic acid suppresses the production of amyloid-beta 1-42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells Neurosci. Res. 75 2013 94 102
73. J.B. Milder, L.P. Liang, and M. Patel Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet Neurobiol. Dis. 40 2010 238 244
74. P. Moi, K. Chan, I. Asunis, A. Cao, and Y.W. Kan Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region Proc. Natl. Acad. Sci. U. S. A. 91 1994 9926 9930 (Pubitemid 24311921)
75. C.D. Morrison, P.J. Pistell, D.K. Ingram, W.D. Johnson, Y. Liu, S.O. Fernandez-Kim, C.L. White, M.N. Purpera, R.M. Uranga, and A.J. Bruce-Keller et al. High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signaling J. Neurochem. 114 2010 1581 1589
76. M.C. Myzak, P.A. Karplus, F.L. Chung, and R.H. Dashwood A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase Cancer Res. 64 2004 5767 5774 (Pubitemid 39095576)
77. S. Naidu, V. Vijayan, S. Santoso, T. Kietzmann, and S. Immenschuh Inhibition and genetic deficiency of p38 MAPK up-regulates heme oxygenase-1 gene expression via Nrf2 J. Immunol. 182 2009 7048 7057
78. S. Nair, S.T. Doh, J.Y. Chan, A.N. Kong, and L. Cai Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesis Br. J. Cancer 99 2008 2070 2082
79. K. Nakaso, H. Yano, Y. Fukuhara, T. Takeshima, K. Wada-Isoe, and K. Nakashima PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells FEBS Lett. 546 2003 181 184 (Pubitemid 36782407)
80. M. Narasimhan, D. Patel, D. Vedpathak, M. Rathinam, G. Henderson, and L. Mahimainathan Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells PLoS One 7 2012 e51111
81. S.K. Niture, and A.K. Jaiswal Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis J. Biol. Chem. 287 2012 9873 9886
82. S.K. Niture, A.K. Jain, and A.K. Jaiswal Antioxidant-induced modification of INrf2 cysteine 151 and PKC-delta-mediated phosphorylation of Nrf2 serine 40 are both required for stabilization and nuclear translocation of Nrf2 and increased drug resistance J. Cell Sci. 122 2009 4452 4464
83. S.K. Niture, A.K. Jain, P.M. Shelton, and A.K. Jaiswal Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression J. Biol. Chem. 286 2011 28821 28832
84. P.E. Pergola, P. Raskin, R.D. Toto, C.J. Meyer, J.W. Huff, E.B. Grossman, M. Krauth, S. Ruiz, P. Audhya, and H. Christ-Schmidt et al. Bardoxolone methyl and kidney function in CKD with type 2 diabetes N. Engl. J. Med. 365 2011 327 336
85. J. Pi, Y. Bai, J.M. Reece, J. Williams, D. Liu, M.L. Freeman, W.E. Fahl, D. Shugar, J. Liu, and W. Qu et al. Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2 Free Radic. Biol. Med. 42 2007 1797 1806 (Pubitemid 46754754)
86. C.A. Piantadosi, C.M. Withers, R.R. Bartz, N.C. MacGarvey, P. Fu, T.E. Sweeney, K.E. Welty-Wolf, and H.B. Suliman Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression J. Biol. Chem. 286 2011 16374 16385
87. A.M. Pickering, R.A. Linder, H. Zhang, H.J. Forman, and K.J. Davies Nrf2-dependent induction of proteasome and Pa28alphabeta regulator are required for adaptation to oxidative stress J. Biol. Chem. 287 2012 10021 10031
88. T. Psaltopoulou, T.N. Sergentanis, D.B. Panagiotakos, I.N. Sergentanis, R. Kosti, and N. Scarmeas Mediterranean diet and stroke, cognitive impairment, depression: a meta-analysis Ann. Neurol. 2013 May 30 Psaltopoulou, et al. Ann Neurol. http://dx.doi.org/10.1002/ana.23944 [Epub ahead of print]
89. P. Rada, A.I. Rojo, N. Evrard-Todeschi, N.G. Innamorato, A. Cotte, T. Jaworski, J.C. Tobon-Velasco, H. Devijver, M.F. Garcia-Mayoral, and F. Van Leuven et al. Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/beta-TrCP axis Mol. Cell. Biol. 32 2012 3486 3499
90. C.P. Ramsey, C.A. Glass, M.B. Montgomery, K.A. Lindl, G.P. Ritson, L.A. Chia, R.L. Hamilton, C.T. Chu, and K.L. Jordan-Sciutto Expression of Nrf2 in neurodegenerative diseases J. Neuropathol. Exp. Neurol. 66 2007 75 85 (Pubitemid 46066791)
91. A.I. Rojo, N.G. Innamorato, A.M. Martin-Moreno, M.L. De Ceballos, M. Yamamoto, and A. Cuadrado Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease Glia 58 2010 588 598
92. H. Sakata, K. Niizuma, H. Yoshioka, G.S. Kim, J.E. Jung, M. Katsu, P. Narasimhan, C.M. Maier, Y. Nishiyama, and P.H. Chan Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats J. Neurosci. 32 2012 3462 3473
93. M. Salazar, A.I. Rojo, D. Velasco, R.M. de Sagarra, and A. Cuadrado Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2 J. Biol. Chem. 281 2006 14841 14851 (Pubitemid 43855189)
94. A. Salminen, K. Kaarniranta, A. Haapasalo, M. Hiltunen, H. Soininen, and I. Alafuzoff Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer's disease Prog. Neurobiol. 96 2012 87 95
95. A. Sarlette, K. Krampfl, C. Grothe, N. Neuhoff, R. Dengler, and S. Petri Nuclear erythroid 2-related factor 2-antioxidative response element signaling pathway in motor cortex and spinal cord in amyotrophic lateral sclerosis J. Neuropathol. Exp. Neurol. 67 2008 1055 1062
96. R.H. Scannevin, S. Chollate, M.Y. Jung, M. Shackett, H. Patel, P. Bista, W. Zeng, S. Ryan, M. Yamamoto, and M. Lukashev et al. Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway J. Pharmacol. Exp. Ther. 341 2012 274 284
97. D.A. Sequea, N. Sharma, E.B. Arias, and G.D. Cartee Calorie restriction enhances insulin-stimulated glucose uptake and Akt phosphorylation in both fast-twitch and slow-twitch skeletal muscle of 24-month-old rats J. Gerontol. A Biol. Sci. Med. Sci. 67 2012 1279 1285
98. Z.A. Shah, R.C. Li, R.K. Thimmulappa, T.W. Kensler, M. Yamamoto, S. Biswal, and S. Dore Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury Neuroscience 147 2007 53 59 (Pubitemid 46881103)
99. A.Y. Shih, P. Li, and T.H. Murphy A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo J. Neurosci. 25 2005 10321 10335 (Pubitemid 41636229)
100. T. Shimazu, M.D. Hirschey, J. Newman, W. He, K. Shirakawa, N. Le Moan, C.A. Grueter, H. Lim, L.R. Saunders, and R.D. Stevens et al. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor Science 339 2013 211 214
101. T.G. Son, S. Camandola, and M.P. Mattson Hormetic dietary phytochemicals Neuromolecular Med. 10 2008 236 246
102. M.B. Sporn, and K.T. Liby NRF2 and cancer: the good, the bad and the importance of context Nat. Rev. Cancer 12 2012 564 571
103. C. Stack, D. Ho, E. Wille, N.Y. Calingasan, C. Williams, K. Liby, M. Sporn, M. Dumont, and M.F. Beal Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease Free Radic. Biol. Med. 49 2010 147 158
104. Z.Y. Su, T.O. Khor, L. Shu, J.H. Lee, C.L. Saw, T.Y. Wu, Y. Huang, N. Suh, C.S. Yang, and A.H. Conney et al. Epigenetic reactivation of Nrf2 in murine prostate cancer TRAMP C1 cells by natural phytochemicals Z-ligustilide and Radix angelica sinensis via promoter CpG demethylation Chem. Res. Toxicol. 26 2013 477 485
105. Z. Sun, Z. Huang, and D.D. Zhang Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response PLoS One 4 2009 e6588
106. Z. Sun, Y.E. Chin, and D.D. Zhang Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response Mol. Cell. Biol. 29 2009 2658 2672
107. K. Tanji, A. Maruyama, S. Odagiri, F. Mori, K. Itoh, A. Kakita, H. Takahashi, and K. Wakabayashi Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases J. Neuropathol. Exp. Neurol. 72 2013 18 28
108. M.H. Teiten, M. Dicato, and M. Diederich Curcumin as a regulator of epigenetic events Mol. Nutr. Food Res. 57 9 2013 1619 1629
109. M.R. Vargas, D.A. Johnson, D.W. Sirkis, A. Messing, and J.A. Johnson Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis J. Neurosci. 28 2008 13574 13581
110. R. Venugopal, and A.K. Jaiswal Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes Oncogene 17 1998 3145 3156 (Pubitemid 29020810)
111. R.F. Villaran, A.M. Espinosa-Oliva, M. Sarmiento, R.M. De Pablos, S. Arguelles, M.J. Delgado-Cortes, V. Sobrino, N. Van Rooijen, J.L. Venero, and A.J. Herrera et al. Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson's disease J. Neurochem. 114 2010 1687 1700
112. M. von Otter, S. Landgren, S. Nilsson, M. Zetterberg, D. Celojevic, P. Bergstrom, L. Minthon, N. Bogdanovic, N. Andreasen, and D.R. Gustafson et al. Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract Mech. Ageing Dev. 131 2010 105 110
113. M. von Otter, S. Landgren, S. Nilsson, D. Celojevic, P. Bergstrom, A. Hakansson, H. Nissbrandt, M. Drozdzik, M. Bialecka, and M. Kurzawski et al. Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease BMC Med. Genet. 11 2010 36
114. X. Wang, P. Svedin, C. Nie, R. Lapatto, C. Zhu, M. Gustavsson, M. Sandberg, J.O. Karlsson, R. Romero, and H. Hagberg et al. N-acetylcysteine reduces lipopolysaccharide-sensitized hypoxic-ischemic brain injury Ann. Neurol. 61 2007 263 271 (Pubitemid 46557350)
115. S. Wang, S. Penchala, S. Prabhu, J. Wang, and Y. Huang Molecular basis of traditional Chinese medicine in cancer chemoprevention Curr. Drug Discov. Technol. 7 2010 67 75
116. J.S. Wang, F.M. Ho, H.C. Kang, W.W. Lin, and K.C. Huang Celecoxib induces heme oxygenase-1 expression in macrophages and vascular smooth muscle cells via ROS-dependent signaling pathway Naunyn Schmiedebergs Arch. Pharmacol. 383 2011 159 168
117. B. Wang, X. Zhu, Y. Kim, J. Li, S. Huang, S. Saleem, R.C. Li, Y. Xu, S. Dore, and W. Cao Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage Free Radic. Biol. Med. 52 2012 928 936
118. Z. Wang, C. Ma, C.J. Meng, G.Q. Zhu, X.B. Sun, L. Huo, J. Zhang, H.X. Liu, W.C. He, and X.M. Shen et al. Melatonin activates the Nrf2-ARE pathway when it protects against early brain injury in a subarachnoid hemorrhage model J. Pineal Res. 53 2012 129 137
119. W. Wang, J. Kang, H. Li, J. Su, J. Wu, Y. Xu, H. Yu, X. Xiang, H. Yi, and Y. Lu et al. Regulation of endoplasmic reticulum stress in rat cortex by p62/ZIP through the Keap1-Nrf2-ARE signalling pathway after transient focal cerebral ischaemia Brain Inj. 27 2013 924 933
120. E. White, C. Karp, A.M. Strohecker, Y. Guo, and R. Mathew Role of autophagy in suppression of inflammation and cancer Curr. Opin. Cell Biol. 22 2010 212 217
121. C. Xu, X. Yuan, Z. Pan, G. Shen, J.H. Kim, S. Yu, T.O. Khor, W. Li, J. Ma, and A.N. Kong Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2 Mol. Cancer Ther. 5 2006 1918 1926 (Pubitemid 44336562)
122. L. Yang, N.Y. Calingasan, B. Thomas, R.K. Chaturvedi, M. Kiaei, E.J. Wille, K.T. Liby, C. Williams, D. Royce, and R. Risingsong et al. Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription PLoS One 4 2009 e5757
123. S. Yasuda, H. Sugiura, H. Tanaka, S. Takigami, and K. Yamagata p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases Cent. Nerv Syst. Agents Med. Chem. 11 2011 45 59
124. M.S. Yates, M. Tauchi, F. Katsuoka, K.C. Flanders, K.T. Liby, T. Honda, G.W. Gribble, D.A. Johnson, J.A. Johnson, and N.C. Burton et al. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes Mol. Cancer Ther. 6 2007 154 162 (Pubitemid 46206678)
125. M. Yu, H. Li, Q. Liu, F. Liu, L. Tang, C. Li, Y. Yuan, Y. Zhan, W. Xu, and W. Li et al. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway Cell Signal 23 2011 883 892
126. D.D. Zhang Bardoxolone brings Nrf2-based therapies to light Antioxid. Redox Signal 19 2013 517 518
127. D.D. Zhang, S.C. Lo, Z. Sun, G.M. Habib, M.W. Lieberman, and M. Hannink Ubiquitination of Keap1, a BTB-Kelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway J. Biol. Chem. 280 2005 30091 30099 (Pubitemid 41216185)
128. Y. Zhu, P.M. Carvey, and Z. Ling Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide Neurochem. Int. 50 2007 671 680 (Pubitemid 46329837)